Imara Announces Recipients of Real Impact Grants Program to Support People Affected by Rare Genetic Blood Disorders
BOSTON, June 25, 2020 (GLOBE NEWSWIRE) — IMARA Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing […]